Yoda Pharmaceuticals Balance Sheet

Financials in millions TWD. Fiscal year is January - December.

Millions TWD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022
Cash & Equivalents	325.38	569.11	34.77	19.2
Short-Term Investments	-	54.74	296.97	-
Cash & Short-Term Investments	325.38	623.85	331.74	19.2
Cash Growth	-47.84%	88.06%	1627.52%	-
Other Receivables	0.88	2.31	2.34	0.07
Receivables	0.88	2.31	2.34	0.07
Prepaid Expenses	2.95	4.28	10.71	0.81
Other Current Assets	669.4	0	-	-
Total Current Assets	998.61	630.45	344.78	20.08
Property, Plant & Equipment	3.2	4.68	1.49	0.44
Other Intangible Assets	8.27	9.25	9.25	9.84
Other Long-Term Assets	7.4	0.08	3.04	0.01
Total Assets	1,017	644.45	358.57	30.36
Accrued Expenses	17.52	13.21	22.02	2.49
Current Portion of Long-Term Debt	-	-	-	9.23
Current Portion of Leases	0.81	0.79	-	-
Other Current Liabilities	12.47	3.55	0.81	0.89
Total Current Liabilities	30.8	17.55	22.83	12.6
Long-Term Leases	-	0.81	-	-
Other Long-Term Liabilities	2.66	-	-	-
Total Liabilities	33.46	18.36	22.83	12.6
Common Stock	793.88	773.88	0.19	0.24
Additional Paid-In Capital	273.18	194.45	501.83	112.86
Retained Earnings	-779.1	-371.88	-179.68	-94.36
Treasury Stock	-	-	-	-0.47
Comprehensive Income & Other	696.06	29.64	12.75	-0.67
Total Common Equity	984.02	626.09	335.09	17.6
Shareholders' Equity	984.02	626.09	335.74	17.76
Total Liabilities & Equity	1,017	644.45	358.57	30.36
Total Debt	0.81	1.6	-	9.23
Net Cash (Debt)	324.57	622.25	331.74	9.97
Net Cash Growth	-47.84%	87.57%	3226.00%	-
Net Cash Per Share	4.10	14.58	27.86	0.85
Filing Date Shares Outstanding	79.39	77.39	79.39	11.67
Total Common Shares Outstanding	79.39	77.39	11.98	11.67
Working Capital	967.81	612.9	321.95	7.48
Book Value Per Share	12.40	8.09	27.96	1.51
Tangible Book Value	975.76	616.85	325.84	7.76
Tangible Book Value Per Share	12.29	7.97	27.19	0.67
Machinery	4.16	3.77	2.06	0.76